Tivic Health Appoints New CEO to Drive Biopharma Pivot
TipRanks (Wed, 4-Mar 8:59 AM ET)
ACCESS Newswire (Wed, 4-Mar 8:30 AM ET)
Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10
ACCESS Newswire (Wed, 18-Feb 9:15 AM ET)
Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting
ACCESS Newswire (Wed, 28-Jan 8:30 AM ET)
ACCESS Newswire (Mon, 26-Jan 10:10 AM ET)
ACCESS Newswire (Fri, 23-Jan 2:51 PM ET)
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
Globe Newswire (Wed, 21-Jan 7:00 AM ET)
Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference
ACCESS Newswire (Tue, 20-Jan 5:50 PM ET)
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream
Globe Newswire (Tue, 20-Jan 7:00 AM ET)
ACCESS Newswire (Thu, 11-Dec 9:45 AM ET)
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Tivic Health Systems trades on the NASDAQ stock market under the symbol TIVC.
As of March 9, 2026, TIVC stock price declined to $0.85 with 407,860 million shares trading.
TIVC has a beta of 1.02, meaning it tends to be more sensitive to market movements. TIVC has a correlation of 0.02 to the broad based SPY ETF.
TIVC has a market cap of $1.49 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, TIVC traded as high as $404.43 and as low as $.72.
The top ETF exchange traded funds that TIVC belongs to (by Net Assets): VXF.
TIVC has underperformed the market in the last year with a return of -80.6%, while the SPY ETF gained +19.7%. In the last 3 month period, TIVC fell short of the market, returning -57.7%, while SPY returned -0.8%. However, in the most recent 2 weeks TIVC has outperformed the stock market by returning +11.3%, while SPY returned -1.6%.
TIVC support price is $.78 and resistance is $.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TIVC shares will trade within this expected range on the day.